|
Volumn 17, Issue 3, 2009, Pages 221-223
|
Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis
|
Author keywords
Bevacizumab; Idiopathic neuroretinitis; Intravitreal injection; Triamcinolone acetonide; Vascular endothelial growth factor
|
Indexed keywords
ANTIGLAUCOMA AGENT;
BEVACIZUMAB;
TRIAMCINOLONE ACETONIDE;
ADULT;
AFFERENT PUPILLARY DEFECT;
ARTICLE;
CASE REPORT;
EYE EXAMINATION;
HUMAN;
IDIOPATHIC NEURORETINITIS;
INTRAOCULAR HYPERTENSION;
MALE;
PAPILLEDEMA;
PAPILLITIS;
RETINA MACULA EDEMA;
RETINITIS;
TREATMENT OUTCOME;
VISUAL ACUITY;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
FLUORESCEIN ANGIOGRAPHY;
GLUCOCORTICOIDS;
HUMANS;
INJECTIONS;
MALE;
PAPILLEDEMA;
RETINITIS;
TOMOGRAPHY, OPTICAL COHERENCE;
TRIAMCINOLONE ACETONIDE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
EID: 68849092817
PISSN: 09273948
EISSN: 17445078
Source Type: Journal
DOI: 10.1080/09273940902731023 Document Type: Article |
Times cited : (9)
|
References (6)
|